📌 𝗪𝗵𝗮𝘁'𝘀 𝗡𝗲𝘄 𝗶𝗻 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 - 𝟮𝟬𝟮𝟱 𝗔𝗗𝗔 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲? скачать в хорошем качестве

📌 𝗪𝗵𝗮𝘁'𝘀 𝗡𝗲𝘄 𝗶𝗻 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 - 𝟮𝟬𝟮𝟱 𝗔𝗗𝗔 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲?

Dear Doctors, It is an honor to present Dr. Bo Bo San’s insights on 📌 “Chronic Kidney Disease and Risk Management”. ✅ Whom and when to screen ✅ How to screen ✅ Diagnosis of Diabetic Kidney Disease ✅ Staging of Chronic Kidney Disease ✅ Interventions? ✅ When do you refer to Nephrologist? 📌 "Diabetes Care in Hospital" ✅ Hospital Care Delivery Standards ✅ Diabetes Care Specialists in the Hospital ✅ Glycemic Goals in Hospitalized Adults ✅ Glucose Monitoring ✅ Insulin Therapy ✅ Noninsulin Therapies ✅ Hypoglycemia ✅ Standards for Special Situations ✅ Diabetic emergencies (DKA / HHS) ✅ Transition from the Hospital to the Ambulatory Setting ✅ Preventing Admissions and Readmissions 📌 This program is organized by the Myanmar Diabetes Association (MMDA) and the Myanmar Society of Endocrinology and Metabolism (MSEM). 💊 This program is proudly supported by 𝗭𝗶𝗴𝗹𝗶𝗽 𝟱𝟬 & 𝟭𝟬𝟬 (𝗦𝗶𝘁𝗮𝗴𝗹𝗶𝗽𝘁𝗶𝗻 𝟱𝟬 𝗺𝗴 & 𝟭𝟬𝟬 𝗺𝗴) 𝗮𝗻𝗱 𝗘𝗺𝗳𝗹𝗼𝘇𝗶𝗻 𝟭𝟬 & 𝟮𝟱 (𝗘𝗺𝗽𝗮𝗴𝗹𝗶𝗳𝗹𝗼𝘇𝗶𝗻 𝟭𝟬 𝗺𝗴 & 𝟮𝟱 𝗺𝗴). #ADA #StandardsofCare #ADAguideline #Recommendations #Diabetes #Hyperglycemia #Screening #ChronicKidneyDisease #CKD #DiabeticKidneyDisease #CardiovascularDisease #GlycemicGoals #Renal #MSEM #MMDA #Ziglip #Sitagliptin #Emflozin #Empagliflozin #Zifam #CaringforWellbeing